Trxade Group (MEDS) Stock Price
Trxade Group Price
Over the last 13 years Trxade Group grew revenue by 29.6% annually, reaching 23.34 M USD. For Trxade Group, the net margin of -433.9% is down versus -15.0% a few years ago. At today's price the dividend yield works out to roughly 3.14%. The consensus 12-month price target for Trxade Group is 6.89 USD, about 127.2% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Trxade Group stock price
Trxade Group business model & stock analysis
Frequently asked questions about Trxade Group
Trxade Group Inc's business model involves operating a web-based healthcare platform, aiming to improve access and affordability of pharmaceutical products to independent pharmacies. The company utilizes technology to connect independent pharmacists with suppliers and manufacturers, creating a transparent marketplace for purchasing and delivering drugs at competitive prices. Trxade Group Inc further offers various services such as prescription and lab testing, consulting, and data analytics to support independent pharmacies in enhancing their operational efficiency and profitability. Through their innovative approach, Trxade Group Inc strives to empower independent pharmacies in the competitive healthcare industry.
Trxade Group Inc is primarily active in the healthcare and pharmaceutical industries.
The main competitors of Trxade Group Inc in the market include pharmaceutical wholesalers and distributors such as McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health Inc. These well-established companies operate on a larger scale compared to Trxade, serving a diverse range of customers including hospitals, retailers, and pharmacies. However, Trxade differentiates itself by focusing on independent pharmacies and providing a comprehensive web-based purchasing platform, offering competitive pricing and efficient inventory management solutions tailored to the needs of its target market.
Trxade Group Inc, founded in 2010, is a leading pharmaceutical supply chain platform in the United States. The company operates Trxade.com, an online marketplace connecting independent pharmacies with suppliers. Trxade's innovative technology and business models aim to revolutionize the healthcare and pharmaceutical industry, promoting fair drug pricing and easier access to medications. With a comprehensive network of pharmacies and suppliers, Trxade Group Inc creates a transparent and efficient marketplace. Its commitment to empowering independent pharmacies has made it a trusted name in the industry. Through continuous advancements and strategic partnerships, Trxade Group Inc continues to shape the future of pharmaceutical commerce.
Trxade Group Inc has achieved several significant milestones in its tenure. The company's key accomplishments include securing a listing on the Nasdaq stock exchange, expanding its reach as a leading web-based pharmaceutical marketplace, and rapidly growing its network of independent pharmacies. Trxade Group Inc has also been recognized for its innovative technologies and solutions, such as its trading platform, which empowers pharmacies to efficiently source medications at competitive prices. This progressive company continues to revolutionize the pharmaceutical industry by connecting independent pharmacies with wholesalers and manufacturers, streamlining operations, and ultimately improving patient access to affordable medications.
Trxade Group Inc is primarily present in the United States.
Trxade Group Inc represents a set of core values and a corporate philosophy that defines its operations. With a focus on transparency, Trxade is dedicated to providing innovative solutions to independent pharmacies, helping them thrive in a competitive industry. The company's commitment to integrity, excellence, and customer-centricity is reflected in its reliable pharmaceutical trading platform and value-added services. Through efficient networking and cost-effective supply chain solutions, Trxade empowers pharmacies to improve patient care while maximizing their profitability. Overall, Trxade Group Inc embodies a customer-first approach, delivering quality products and services to the pharmaceutical industry.
Analysts currently set an average price target of 6.89 USD for the Trxade Group stock (median: 6.89 USD), implying +127.2 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Trxade Group stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Trxade Group share trades at 2.70 EUR (3.03 USD).
The Trxade Group Inc is a leading company in the healthcare sector, offering innovative solutions to improve efficiency, quality, and transparency in the pharmaceutical supply chain to businesses and individuals. The company operates multiple divisions and provides a variety of products and services to meet customer needs.
The revenue cannot currently be calculated for Trxade Group.
The profit cannot currently be calculated for Trxade Group.
The P/E ratio cannot be calculated for Trxade Group at the moment.
The P/S cannot be calculated for Trxade Group currently.
The Eulerpool Quality Score for Trxade Group is 2/10.
The ISIN of Trxade Group is US89846A2078. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Trxade Group is MEDS. The ticker symbol is used to trade Trxade Group shares on the stock exchange.
Trxade Group stock
Trxade Group Peer Group
Trxade Group FIGI
All fundamentals and in-depth analysis of Trxade Group
Our stock analysis for Trxade Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trxade Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.